Opus Genetics, Inc. (Nasdaq: IRD) announced it has reached alignment with the U.S. Food and Drug Administration on the design ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE